CA2403974A1 - Methode et dispositif permettant de mesurer objectivement la douleur, les traitements anti-douleur et autres techniques connexes - Google Patents
Methode et dispositif permettant de mesurer objectivement la douleur, les traitements anti-douleur et autres techniques connexes Download PDFInfo
- Publication number
- CA2403974A1 CA2403974A1 CA002403974A CA2403974A CA2403974A1 CA 2403974 A1 CA2403974 A1 CA 2403974A1 CA 002403974 A CA002403974 A CA 002403974A CA 2403974 A CA2403974 A CA 2403974A CA 2403974 A1 CA2403974 A1 CA 2403974A1
- Authority
- CA
- Canada
- Prior art keywords
- regions
- response
- brain
- signal
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 198
- 208000002193 Pain Diseases 0.000 title claims abstract description 196
- 230000036407 pain Effects 0.000 title claims abstract description 176
- 238000011282 treatment Methods 0.000 title claims description 16
- 230000004044 response Effects 0.000 claims abstract description 332
- 210000004556 brain Anatomy 0.000 claims abstract description 227
- 230000000694 effects Effects 0.000 claims abstract description 116
- 210000003169 central nervous system Anatomy 0.000 claims abstract description 104
- 230000008569 process Effects 0.000 claims abstract description 43
- 230000007177 brain activity Effects 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 230000004913 activation Effects 0.000 claims description 252
- 230000008859 change Effects 0.000 claims description 122
- 206010063659 Aversion Diseases 0.000 claims description 91
- 230000006870 function Effects 0.000 claims description 77
- 238000004458 analytical method Methods 0.000 claims description 68
- 238000002599 functional magnetic resonance imaging Methods 0.000 claims description 61
- 239000003814 drug Substances 0.000 claims description 51
- 229940079593 drug Drugs 0.000 claims description 50
- 230000002123 temporal effect Effects 0.000 claims description 39
- 210000004727 amygdala Anatomy 0.000 claims description 34
- 238000002610 neuroimaging Methods 0.000 claims description 30
- 210000001103 thalamus Anatomy 0.000 claims description 28
- 238000003384 imaging method Methods 0.000 claims description 25
- 238000013507 mapping Methods 0.000 claims description 24
- 210000000133 brain stem Anatomy 0.000 claims description 19
- 239000011159 matrix material Substances 0.000 claims description 19
- 230000004807 localization Effects 0.000 claims description 18
- 230000033001 locomotion Effects 0.000 claims description 18
- 210000003016 hypothalamus Anatomy 0.000 claims description 16
- 239000000902 placebo Substances 0.000 claims description 14
- 229940068196 placebo Drugs 0.000 claims description 14
- 210000002442 prefrontal cortex Anatomy 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 230000003542 behavioural effect Effects 0.000 claims description 11
- 230000000202 analgesic effect Effects 0.000 claims description 9
- 230000002739 subcortical effect Effects 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 210000000278 spinal cord Anatomy 0.000 claims description 8
- 238000010219 correlation analysis Methods 0.000 claims description 7
- 238000001228 spectrum Methods 0.000 claims description 6
- 210000001638 cerebellum Anatomy 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 210000001320 hippocampus Anatomy 0.000 claims description 4
- 238000002603 single-photon emission computed tomography Methods 0.000 claims description 4
- 238000010183 spectrum analysis Methods 0.000 claims description 4
- 210000000836 trigeminal nuclei Anatomy 0.000 claims description 4
- 229960000074 biopharmaceutical Drugs 0.000 claims description 3
- 210000001029 dorsal striatum Anatomy 0.000 claims description 3
- 238000011287 therapeutic dose Methods 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims 2
- 238000013528 artificial neural network Methods 0.000 claims 2
- 230000001722 neurochemical effect Effects 0.000 claims 2
- 238000001467 acupuncture Methods 0.000 claims 1
- 230000019522 cellular metabolic process Effects 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 claims 1
- 230000010412 perfusion Effects 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 238000012732 spatial analysis Methods 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000005062 synaptic transmission Effects 0.000 claims 1
- 238000012731 temporal analysis Methods 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 19
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 238000011422 pharmacological therapy Methods 0.000 abstract 1
- 238000001994 activation Methods 0.000 description 251
- 238000002474 experimental method Methods 0.000 description 118
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 52
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 50
- 238000012545 processing Methods 0.000 description 49
- 230000000875 corresponding effect Effects 0.000 description 38
- 230000002996 emotional effect Effects 0.000 description 34
- 238000012360 testing method Methods 0.000 description 34
- 238000010586 diagram Methods 0.000 description 33
- 230000007935 neutral effect Effects 0.000 description 30
- 230000006399 behavior Effects 0.000 description 28
- 238000011156 evaluation Methods 0.000 description 28
- 229960003920 cocaine Drugs 0.000 description 27
- 238000001802 infusion Methods 0.000 description 27
- 239000000523 sample Substances 0.000 description 27
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 26
- 229960005181 morphine Drugs 0.000 description 26
- 238000000540 analysis of variance Methods 0.000 description 23
- 230000008451 emotion Effects 0.000 description 23
- 230000002596 correlated effect Effects 0.000 description 22
- 238000005259 measurement Methods 0.000 description 21
- 230000008450 motivation Effects 0.000 description 21
- 230000000284 resting effect Effects 0.000 description 21
- 239000011780 sodium chloride Substances 0.000 description 20
- 238000012935 Averaging Methods 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 238000012937 correction Methods 0.000 description 18
- 238000002595 magnetic resonance imaging Methods 0.000 description 18
- 238000013459 approach Methods 0.000 description 17
- 239000006185 dispersion Substances 0.000 description 17
- 230000001953 sensory effect Effects 0.000 description 17
- 230000001473 noxious effect Effects 0.000 description 16
- 229960002504 capsaicin Drugs 0.000 description 15
- 230000007423 decrease Effects 0.000 description 15
- 208000004454 Hyperalgesia Diseases 0.000 description 14
- 230000000004 hemodynamic effect Effects 0.000 description 14
- 230000001154 acute effect Effects 0.000 description 13
- 235000017663 capsaicin Nutrition 0.000 description 13
- 238000009826 distribution Methods 0.000 description 12
- 230000003993 interaction Effects 0.000 description 12
- 208000000094 Chronic Pain Diseases 0.000 description 11
- 206010053552 allodynia Diseases 0.000 description 10
- 230000001537 neural effect Effects 0.000 description 10
- 230000027758 ovulation cycle Effects 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 230000035479 physiological effects, processes and functions Effects 0.000 description 9
- 210000004092 somatosensory cortex Anatomy 0.000 description 9
- 230000000638 stimulation Effects 0.000 description 9
- 241000282412 Homo Species 0.000 description 8
- 230000000747 cardiac effect Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 238000002600 positron emission tomography Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000007619 statistical method Methods 0.000 description 8
- 238000000692 Student's t-test Methods 0.000 description 7
- 208000005298 acute pain Diseases 0.000 description 7
- 230000001149 cognitive effect Effects 0.000 description 7
- 238000007405 data analysis Methods 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 210000004129 prosencephalon Anatomy 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 230000006978 adaptation Effects 0.000 description 6
- 230000003796 beauty Effects 0.000 description 6
- 230000002146 bilateral effect Effects 0.000 description 6
- 230000001054 cortical effect Effects 0.000 description 6
- 210000004884 grey matter Anatomy 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 6
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 6
- 229960004127 naloxone Drugs 0.000 description 6
- 208000004296 neuralgia Diseases 0.000 description 6
- 208000021722 neuropathic pain Diseases 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 206010052804 Drug tolerance Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 235000019788 craving Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000026781 habituation Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000010365 information processing Effects 0.000 description 5
- 238000002582 magnetoencephalography Methods 0.000 description 5
- 230000015654 memory Effects 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 208000020016 psychiatric disease Diseases 0.000 description 5
- 230000011218 segmentation Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 238000010972 statistical evaluation Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 208000035154 Hyperesthesia Diseases 0.000 description 4
- 244000223014 Syzygium aromaticum Species 0.000 description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 238000013542 behavioral therapy Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000008921 facial expression Effects 0.000 description 4
- 210000004326 gyrus cinguli Anatomy 0.000 description 4
- 230000003447 ipsilateral effect Effects 0.000 description 4
- 230000029849 luteinization Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008447 perception Effects 0.000 description 4
- 230000002360 prefrontal effect Effects 0.000 description 4
- 230000036387 respiratory rate Effects 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 240000007320 Pinus strobus Species 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000001652 frontal lobe Anatomy 0.000 description 3
- 230000002197 limbic effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004890 malting Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 210000001009 nucleus accumben Anatomy 0.000 description 3
- 230000011599 ovarian follicle development Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000026416 response to pain Effects 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 230000003238 somatosensory effect Effects 0.000 description 3
- 208000011117 substance-related disease Diseases 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000003478 temporal lobe Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000282836 Camelus dromedarius Species 0.000 description 2
- 241001079597 Colus Species 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000001613 Gambling Diseases 0.000 description 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000000589 amygdalar effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000010420 art technique Methods 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- HGBLNBBNRORJKI-WCABBAIRSA-N cyclacillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C1(N)CCCCC1 HGBLNBBNRORJKI-WCABBAIRSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000009699 differential effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000006397 emotional response Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011985 exploratory data analysis Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000003325 follicular Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000003284 homeostatic effect Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 210000002425 internal capsule Anatomy 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000004879 molecular function Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000002450 orbitofrontal effect Effects 0.000 description 2
- 238000003909 pattern recognition Methods 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 230000006461 physiological response Effects 0.000 description 2
- 238000013105 post hoc analysis Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002287 radioligand Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000031893 sensory processing Effects 0.000 description 2
- 230000008326 skin blood flow Effects 0.000 description 2
- 238000012421 spiking Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 208000037595 EN1-related dorsoventral syndrome Diseases 0.000 description 1
- 241001539473 Euphoria Species 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 101100389355 Mus musculus Endov gene Proteins 0.000 description 1
- 238000010220 Pearson correlation analysis Methods 0.000 description 1
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 208000027520 Somatoform disease Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000008649 adaptation response Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000974 brodmann area Anatomy 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000000877 corpus callosum Anatomy 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000007120 differential activation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 230000010491 emotional process Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000001353 entorhinal cortex Anatomy 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- ZEKANFGSDXODPD-UHFFFAOYSA-N glyphosate-isopropylammonium Chemical compound CC(C)N.OC(=O)CNCP(O)(O)=O ZEKANFGSDXODPD-UHFFFAOYSA-N 0.000 description 1
- 101150086005 gob-1 gene Proteins 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000005032 impulse control Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002075 inversion recovery Methods 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005960 long-lasting response Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001073 mediodorsal thalamic nucleus Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000337 motor cortex Anatomy 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003557 neuropsychological effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003040 nociceptive effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000005112 optic tract Anatomy 0.000 description 1
- 230000004421 optic tracts Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 210000001152 parietal lobe Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 210000002509 periaqueductal gray Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005997 psychological dysfunction Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000002637 putamen Anatomy 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010244 region-of-interest analysis Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000013432 robust analysis Methods 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008914 somatic perception Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 238000011410 subtraction method Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000004001 thalamic nuclei Anatomy 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4824—Touch or pain perception evaluation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- High Energy & Nuclear Physics (AREA)
- Hospice & Palliative Care (AREA)
- Radiology & Medical Imaging (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Social Psychology (AREA)
- Educational Technology (AREA)
- Developmental Disabilities (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19330000P | 2000-03-30 | 2000-03-30 | |
| US60/193,300 | 2000-03-30 | ||
| US22895000P | 2000-08-28 | 2000-08-28 | |
| US60/228,950 | 2000-08-28 | ||
| US72966500A | 2000-12-04 | 2000-12-04 | |
| US09/729,665 | 2000-12-04 | ||
| PCT/US2001/010377 WO2001074240A2 (fr) | 2000-03-30 | 2001-03-30 | Methode et dispositif permettant de mesurer objectivement la douleur, les traitements anti-douleur et autres techniques connexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2403974A1 true CA2403974A1 (fr) | 2001-10-11 |
Family
ID=27393183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002403974A Abandoned CA2403974A1 (fr) | 2000-03-30 | 2001-03-30 | Methode et dispositif permettant de mesurer objectivement la douleur, les traitements anti-douleur et autres techniques connexes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1272105A2 (fr) |
| JP (1) | JP2003528679A (fr) |
| AU (1) | AU2001253040A1 (fr) |
| CA (1) | CA2403974A1 (fr) |
| WO (1) | WO2001074240A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112789632A (zh) * | 2019-08-08 | 2021-05-11 | 西姆莱斯有限公司 | 对感官刺激的长期感情反应的预测 |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2838040B1 (fr) * | 2002-04-03 | 2004-07-02 | Oreal | Procede pour verifier l'efficacite d'un produit destine a exercer une action sur la sensibilite de la peau |
| JP2005528937A (ja) * | 2002-04-05 | 2005-09-29 | ホルツナー、オリヴァー | 脳活動の電磁修正のための方法と装置 |
| AU2003259846A1 (en) * | 2002-08-16 | 2004-03-03 | The General Hospital Corporation | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
| US7447541B2 (en) | 2004-06-30 | 2008-11-04 | Instrumentarium Corporation | Monitoring subcortical responsiveness of a patient |
| EP1637075A1 (fr) * | 2004-09-20 | 2006-03-22 | Centre Hospitalier Regional Universitaire de Lille | Procédé et dispositif d'évaluation de la douleur chez un être vivant |
| JP4728886B2 (ja) * | 2006-06-20 | 2011-07-20 | 日本電信電話株式会社 | 知覚情報提示装置 |
| US9402558B2 (en) * | 2007-04-05 | 2016-08-02 | New York University | System and method for pain detection and computation of a pain quantification index |
| WO2009077910A1 (fr) * | 2007-12-14 | 2009-06-25 | Koninklijke Philips Electronics N.V. | Analyse d'image notamment de données d'image du cerveau |
| CA2728647A1 (fr) * | 2008-06-24 | 2009-12-30 | Dainippon Sumitomo Pharma Co., Ltd. | Dispositif de jugement de la douleur |
| EP2284576B1 (fr) | 2009-07-31 | 2013-07-10 | Deutsche Telekom AG | Procédé et système de prévision d'événements |
| CA2795045C (fr) * | 2010-03-30 | 2022-07-05 | Julia Cole Finkel | Appareil et procede pour l'algometrie humaine |
| WO2014076795A1 (fr) * | 2012-11-15 | 2014-05-22 | 株式会社島津製作所 | Dispositif biométrique optique |
| AU2015266749B2 (en) | 2014-05-30 | 2021-02-04 | Leidos Innovations Technology, Inc. | Method and system for signal processing |
| JP6583719B2 (ja) * | 2015-07-24 | 2019-10-02 | 国立研究開発法人情報通信研究機構 | 情報処理装置の作動方法および推定システム |
| KR102081839B1 (ko) * | 2017-12-14 | 2020-02-27 | 김효준 | 정량화된 고통민감도측정장치 및 그 방법 |
| CN110090017B (zh) * | 2019-03-11 | 2021-09-14 | 北京工业大学 | 一种基于lstm的脑电信号源定位方法 |
| CN110742604B (zh) * | 2019-09-20 | 2022-04-01 | 复旦大学附属华山医院 | 一种正中神经电刺激下基于皮层脑电的脑功能定位方法 |
| JP6841982B1 (ja) * | 2019-10-31 | 2021-03-10 | 楽天株式会社 | コアレート生成装置、コアレート生成方法およびプログラム |
| JP7193563B2 (ja) * | 2021-02-18 | 2022-12-20 | 楽天グループ株式会社 | コアレート生成装置、コアレート生成方法およびプログラム |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19529639C2 (de) * | 1995-08-11 | 1997-06-19 | Siemens Ag | Verfahren zur zeit- und ortsaufgelösten Darstellung funktioneller Gehirnaktivitäten eines Patienten und Anordnung zur Durchführung des Verfahrens |
| US5676138A (en) * | 1996-03-15 | 1997-10-14 | Zawilinski; Kenneth Michael | Emotional response analyzer system with multimedia display |
-
2001
- 2001-03-30 WO PCT/US2001/010377 patent/WO2001074240A2/fr not_active Application Discontinuation
- 2001-03-30 CA CA002403974A patent/CA2403974A1/fr not_active Abandoned
- 2001-03-30 AU AU2001253040A patent/AU2001253040A1/en not_active Abandoned
- 2001-03-30 EP EP01926507A patent/EP1272105A2/fr not_active Withdrawn
- 2001-03-30 JP JP2001571988A patent/JP2003528679A/ja not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112789632A (zh) * | 2019-08-08 | 2021-05-11 | 西姆莱斯有限公司 | 对感官刺激的长期感情反应的预测 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1272105A2 (fr) | 2003-01-08 |
| WO2001074240A3 (fr) | 2002-05-23 |
| AU2001253040A1 (en) | 2001-10-15 |
| WO2001074240A2 (fr) | 2001-10-11 |
| JP2003528679A (ja) | 2003-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6907280B2 (en) | Method and apparatus for objectively measuring pain, pain treatment and other related techniques | |
| US20020058867A1 (en) | Method and apparatus for measuring indices of brain activity during motivational and emotional function | |
| US7627370B2 (en) | Brain function decoding process and system | |
| CA2403974A1 (fr) | Methode et dispositif permettant de mesurer objectivement la douleur, les traitements anti-douleur et autres techniques connexes | |
| Berman et al. | Does resting-state connectivity reflect depressive rumination? A tale of two analyses | |
| JP6195329B1 (ja) | 脳活動解析装置、脳活動解析方法、プログラムおよびバイオマーカー装置 | |
| Friston et al. | Comparing functional (PET) images: the assessment of significant change | |
| US20140316248A1 (en) | Methods for measurement and analysis of brain activity | |
| WO2014178322A1 (fr) | Dispositif d'entraînement cérébral ainsi que système d'entraînement cérébral | |
| US20100249573A1 (en) | Brain function decoding process and system | |
| CN105163659A (zh) | 脑活动分析装置、脑活动分析方法以及生物标记物装置 | |
| JP6875054B2 (ja) | 脳活動訓練装置、脳活動訓練方法および脳活動訓練プログラム | |
| US20100135911A1 (en) | Spatial evolution of neural activity | |
| Van Buuren et al. | Functional network interactions at rest underlie individual differences in memory ability | |
| Vaghela et al. | Functional magnetic resonance imaging of the brain: A quick review | |
| Amey et al. | Neural mechanisms associated with semantic and basic self-oriented memory processes interact moderating self-esteem | |
| US20230352141A1 (en) | Screening, monitoring, and treatment framework for focused ultrasound | |
| Duru et al. | Investigaton of the neuronal efficacy and EEG source power under steady-state visual stimulation | |
| Marques | EEG Spectral Analysis as a Predictor of Popularity | |
| Sande | Effects of yoga experience compared to exercise on functional connectivity in distributed brain networks | |
| Lesnewich | Resting-state functional connectivity and depression: toward neural mechanisms of depression, rumination, and emotion dysregulation | |
| L'Heureux | Neural correlates relating to executive function, intelligence, and anxiety. | |
| Wu | Functional network study on the wild type and DISC1 transgenic mice | |
| Pergola | Involvement of the human thalamus and its cortical network in recognition memory and recall | |
| Cociu et al. | Multimodal functional and structural brain connectivity analysis in autism: A preliminary integrated |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |